"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","characteristics_ch1.4","characteristics_ch1.5","characteristics_ch1.6","characteristics_ch1.7","characteristics_ch1.8","characteristics_ch1.9","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","data_processing","platform_id","contact_name","contact_email","contact_department","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","relation"
"GSM795125","serous ovarian cancer 106","GSM795125","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 15","rec (1): 1","os (m): 26","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795125/GSM795125_s106.txt.gz","41093","Reanalysis of: GSM432223"
"GSM795126","serous ovarian cancer 108","GSM795126","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 37","rec (1): 0","os (m): 37","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795126/GSM795126_s108.txt.gz","41093","Reanalysis of: GSM432225"
"GSM795127","serous ovarian cancer 109R","GSM795127","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 7","rec (1): 1","os (m): 20","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795127/GSM795127_s109R.txt.gz","41093","Reanalysis of: GSM432226"
"GSM795128","serous ovarian cancer 110","GSM795128","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 97","rec (1): 0","os (m): 97","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795128/GSM795128_s110.txt.gz","41093","Reanalysis of: GSM432228"
"GSM795129","serous ovarian cancer 111R","GSM795129","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 18","rec (1): 1","os (m): 57","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795129/GSM795129_s111R.txt.gz","41093","Reanalysis of: GSM432229"
"GSM795130","serous ovarian cancer 192","GSM795130","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 20","rec (1): 1","os (m): 27","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795130/GSM795130_s192.txt.gz","41093",""
"GSM795131","serous ovarian cancer 195R","GSM795131","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 6","rec (1): 1","os (m): 40","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795131/GSM795131_s195R.txt.gz","41093",""
"GSM795132","serous ovarian cancer 196","GSM795132","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 28","rec (1): 1","os (m): 37","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795132/GSM795132_s196.txt.gz","41093",""
"GSM795133","serous ovarian cancer 197","GSM795133","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 47","rec (1): 0","os (m): 47","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795133/GSM795133_s197.txt.gz","41093",""
"GSM795134","serous ovarian cancer 198","GSM795134","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 8","rec (1): 1","os (m): 24","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795134/GSM795134_s198.txt.gz","41093",""
"GSM795135","serous ovarian cancer 200","GSM795135","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 6","rec (1): 1","os (m): 27","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795135/GSM795135_s200.txt.gz","41093",""
"GSM795136","serous ovarian cancer 203","GSM795136","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 26","rec (1): 1","os (m): 46","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795136/GSM795136_s203.txt.gz","41093",""
"GSM795137","serous ovarian cancer 205","GSM795137","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 43","rec (1): 1","os (m): 78","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795137/GSM795137_s205.txt.gz","41093",""
"GSM795138","serous ovarian cancer 206","GSM795138","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 21","rec (1): 1","os (m): 87","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795138/GSM795138_s206.txt.gz","41093",""
"GSM795139","serous ovarian cancer 207","GSM795139","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 30","rec (1): 0","os (m): 30","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795139/GSM795139_s207.txt.gz","41093",""
"GSM795140","serous ovarian cancer 213","GSM795140","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 15","rec (1): 1","os (m): 35","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795140/GSM795140_s213.txt.gz","41093",""
"GSM795141","serous ovarian cancer 222","GSM795141","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 0","os (m): 12","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795141/GSM795141_s222.txt.gz","41093",""
"GSM795142","serous ovarian cancer 224","GSM795142","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 11","rec (1): 1","os (m): 16","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795142/GSM795142_s224.txt.gz","41093",""
"GSM795143","serous ovarian cancer 226","GSM795143","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 11","rec (1): 0","os (m): 11","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795143/GSM795143_s226.txt.gz","41093",""
"GSM795144","serous ovarian cancer 229","GSM795144","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 9","rec (1): 0","os (m): 9","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795144/GSM795144_s229.txt.gz","41093",""
"GSM795145","serous ovarian cancer 230","GSM795145","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IV","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 8","rec (1): 0","os (m): 8","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795145/GSM795145_s230.txt.gz","41093",""
"GSM795146","serous ovarian cancer 231","GSM795146","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 7","rec (1): 0","os (m): 7","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795146/GSM795146_s231.txt.gz","41093",""
"GSM795147","serous ovarian cancer 274","GSM795147","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 35","rec (1): 1","os (m): 101","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795147/GSM795147_s274.txt.gz","41093",""
"GSM795148","serous ovarian cancer 277","GSM795148","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 73","rec (1): 1","os (m): 109","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795148/GSM795148_s277.txt.gz","41093",""
"GSM795149","serous ovarian cancer 278","GSM795149","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 16","rec (1): 1","os (m): 21","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795149/GSM795149_s278.txt.gz","41093",""
"GSM795150","serous ovarian cancer 280","GSM795150","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 68","rec (1): 0","os (m): 68","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795150/GSM795150_s280.txt.gz","41093",""
"GSM795151","serous ovarian cancer 281","GSM795151","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 8","rec (1): 1","os (m): 15","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795151/GSM795151_s281.txt.gz","41093",""
"GSM795152","serous ovarian cancer 282","GSM795152","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 82","rec (1): 0","os (m): 82","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795152/GSM795152_s282.txt.gz","41093",""
"GSM795153","serous ovarian cancer 283","GSM795153","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 49","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795153/GSM795153_s283.txt.gz","41093",""
"GSM795154","serous ovarian cancer 284","GSM795154","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 111","rec (1): 0","os (m): 111","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795154/GSM795154_s284.txt.gz","41093",""
"GSM795155","serous ovarian cancer 285","GSM795155","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 82","rec (1): 0","os (m): 82","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795155/GSM795155_s285.txt.gz","41093",""
"GSM795156","serous ovarian cancer 286","GSM795156","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 8","rec (1): 1","os (m): 22","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795156/GSM795156_s286.txt.gz","41093",""
"GSM795157","serous ovarian cancer 287","GSM795157","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 12","rec (1): 1","os (m): 40","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795157/GSM795157_s287.txt.gz","41093",""
"GSM795158","serous ovarian cancer 288","GSM795158","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 9","rec (1): 1","os (m): 24","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795158/GSM795158_s288.txt.gz","41093",""
"GSM795159","serous ovarian cancer 289","GSM795159","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIb","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 14","rec (1): 1","os (m): 40","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795159/GSM795159_s289.txt.gz","41093",""
"GSM795160","serous ovarian cancer 291","GSM795160","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 15","rec (1): 1","os (m): 48","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795160/GSM795160_s291.txt.gz","41093",""
"GSM795161","serous ovarian cancer 292","GSM795161","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 28","rec (1): 1","os (m): 54","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795161/GSM795161_s292.txt.gz","41093",""
"GSM795162","serous ovarian cancer 294","GSM795162","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 3","Stage: IIIc","surgery status: optimal","taxane: 1","platinum: 1","pfs (m): 49","rec (1): 1","os (m): 70","death (1): 0","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795162/GSM795162_s294.txt.gz","41093",""
"GSM795163","serous ovarian cancer 297R","GSM795163","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 2","rec (1): 1","os (m): 24","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795163/GSM795163_s297R.txt.gz","41093",""
"GSM795164","serous ovarian cancer 298R","GSM795164","Public on Mar 01 2012","Sep 12 2011","Mar 01 2012","RNA","1","high-grade serous ovarian cancer","Homo sapiens","tissue: tumor","grading: 2","Stage: IV","surgery status: suboptimal","taxane: 1","platinum: 1","pfs (m): 31","rec (1): 1","os (m): 57","death (1): 1","total RNA","Total RNA was extracted from tissue samples using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's recommendations. RNA was examined with a 2100 Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA, USA) using an RNA 6000 Nano LabChip (Agilent Technologies)","Cy3","Cyanine-3 (Cy3) labeled cRNA was prepared from 0.5 ug RNA using the Quick Amp Labering Kit, one-color (Agilent Technologies) according to the manufacturer's instructions, followed by RNAeasy column purification (QIAGEN, Valencia, CA).","9606","Cy3-labeled cRNAs (1.65 µg) were hybridized for 17 hours at 65°C to an Agilent Whole Human Genome Oligo Microarray in a rotating Agilent hybridization oven.","The hybridized microarray was washed and then scanned in Cy3 channel with the Agilent DNA Microarray Scanner (model G2565AA).","Signal intensity per spot was generated from the scanned image with Feature Extraction Software ver.9.1 (Agilent Technologies) in the default settings.","GPL6480","Kosuke,,Yoshihara","yoshikou@med.niigata-u.ac.jp","Obstetrics and Gynecology","Niigata University","1-757 Asahimachi-dori","Niigata","951-8510","Japan","ftp://ftp.ncbi.nih.gov/pub/geo/DATA/supplementary/samples/GSM795nnn/GSM795164/GSM795164_s298R.txt.gz","41093",""
